Search - tctmd.com

Displaying 241 - 260 of 1148

Sort: Relevancy | Date

Presentation TCT 2018

Ultra-Thin Strut DES: A Meaningful Advance?

Presenter: Renu Virmani, Clemens von Birgelen, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Presenter: Renu Virmani, Clemens von Birgelen, David E. Kandzari

September 22, 2018

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

Presentation TCT 2018

TCT-115: Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Presenter: J. Michael Bacharach, Tony Das, Thijs Wakkie

September 21, 2018

Presentation TCT 2018

TCT-80: Natural Change of the Distal Bed Following Percutaneous Coronary Intervention With Drug-Eluting Stents for Chronic Total Occlusion Lesions

Presenter: Kevin J. Croce, Dimitri Karmpaliotis, Osung Kwon

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Daily News

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Michael O'Riordan

July 20, 2018

News Daily News

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

Caitlin E. Cox

June 28, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

News Industry News

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

May 24, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

Presentation Fellows 2018

The Evolution of Drug-Eluting Stents

Presenter: Manish A. Parikh, Gregg W. Stone

April 13, 2018

News Industry News

Micell Technologies Announces Expanded Patent Estate - Issued Key Patents Significantly Strengthen Company’s Proprietary Rights in Surface Modification and Controlled Drug Delivery

March 21, 2018

Advertisement

Ultra-Thin Strut DES: A Meaningful Advance?

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

TCT-115: Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

TCT-80: Natural Change of the Distal Bed Following Percutaneous Coronary Intervention With Drug-Eluting Stents for Chronic Total Occlusion Lesions

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

The Evolution of Drug-Eluting Stents

Micell Technologies Announces Expanded Patent Estate - Issued Key Patents Significantly Strengthen Company’s Proprietary Rights in Surface Modification and Controlled Drug Delivery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content